NBC Securities
INBX icon

NBC Securities’s Inhibrx INBX Stock Holding History

NBC Securities’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$323K Sell
3,225
-675
-17% -$67.3K 0.02% 682
2026
Q2 		$370K Buy
3,900
+100
+3% +$10K 0.03% 642
2026
Q1 		$255K Buy
3,800
+800
+27% +$59.3K 0.02% 760
2025
Q4 		$237K Hold
3,000
– – 0.02% 781
2025
Q3 		$101K Buy
+3,000
New +$73.9K 0.01% 1068

Other funds holding INBX

Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Capitolis Liquid Global Markets
Capitolis Liquid Global Markets New York $22.4B AUM 40.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

NBC Securities's INBX Position: Q3 2026 in Review

NBC Securities reduced its Inhibrx (INBX) stake by 17% in Q3 2026, selling an estimated $67.3K and leaving 3,225 shares worth $323K. The position accounts for 0.02% of the portfolio, ranked #682.

NBC Securities first reported a position in INBX in Q3 2025 and has held it in 5 quarters since. The position peaked at $370K in Q2 2026. 90 funds tracked by Wall St. Rank hold INBX as of Q3 2026.

  • NBC Securities held 3,225 shares of Inhibrx worth $323K as of Q3 2026.
  • NBC Securities sold 675 Inhibrx shares in Q3 2026, an estimated $67.3K.
  • Inhibrx made up 0.02% of NBC Securities's portfolio in Q3 2026, its #682 holding.
  • NBC Securities first reported a position in Inhibrx in Q3 2025 and has held it in 5 quarters since.
  • NBC Securities's Inhibrx position peaked at $370K in Q2 2026.
  • 90 funds tracked by Wall St. Rank held Inhibrx as of Q3 2026.

Based on NBC Securities's 13F filing for Q3 2026, filed 26 Oct 2026.